Production of lentiviral vectors

Merten, Otto-Wilhelm, Hebben, Matthias, Bovolenta, Chiara·2016·Molecular Therapy - Methods & Clinical Development

Cited by (294)

Items 101–200 of 294

  1. Continuous manufacturing of lentiviral vectors using a stable producer cell line in a fixed-bed bioreactor
    Dale J. Stibbs, Pedro Silva Couto, Yasuhiro Takeuchi, Qasim A. Rafiq, Nigel B. Jackson, Andrea C. M. E. Rayat · 2024 · Molecular Therapy — Methods & Clinical Development
  2. Progressing from transient to stable packaging cell lines for continuous production of lentiviral and gammaretroviral vectors
    Jaeyoung Park, Sarah Inwood, Srivalli Kruthiventi, Jackson P. Jenkins, Joseph Shiloach, Michael J. Betenbaugh · 2018 · Current Opinion in Chemical Engineering
  3. Enzymatically amplified linear dbDNATM as a rapid and scalable solution to industrial lentiviral vector manufacturing
    Maria Barreira, Claire Kerridge, Sara Jorda, Didrik Olofsson, Alexander Neumann, Helen Horton, Sarah Smith‐Moore · 2022 · Gene Therapy
  4. Packaging cells for lentiviral vectors generated using the cumate and coumermycin gene induction systems and nanowell single-cell cloning
    Sophie Broussau, Viktoria Lytvyn, Mélanie Simoneau, Claire Guilbault, Mélanie Leclerc, Nazila Nazemi-Moghaddam, Nathalie Coulombe, Seyyed Mehdy Elahi, Scott McComb, Rénald Gilbert · 2023 · Molecular Therapy — Methods & Clinical Development
  5. Digital Twin for Continuous Production of Virus-like Particles toward Autonomous Operation
    Alina Hengelbrock, Finja Probst, Simon Baukmann, Alexander Uhl, Natalie Tschorn, Jörn Stitz, A. Schmidt, Jochen Strube · 2024 · ACS Omega
  6. The Superiority of Sucrose Cushion Centrifugation to Ultrafiltration and PEGylation in Generating High-Titer Lentivirus Particles and Transducing Stem Cells with Enhanced Efficiency
    Mahdi Eskandarian Boroujeni, Mossa Gardaneh · 2018 · Molecular Biotechnology
  7. Cocaine‐ and amphetamine‐regulated transcript peptide in the nucleus accumbens shell inhibits cocaine‐induced locomotor sensitization to transient over‐expression of α‐Ca2+/calmodulin‐dependent protein kinase II
    Lixia Xiong, Meng Qing, Xi Sun, Xiangtong Lu, Qiang Fu, Qinghua Peng, Jianhua Yang, Ki‐Wan Oh, Zhenzhen Hu · 2018 · Journal of Neurochemistry
  8. Bioprocess monitoring and control: challenges in cell and gene therapy
    Joe Emerson, Jarka Glassey · 2021 · Current Opinion in Chemical Engineering
  9. End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics
    Annette M. Medina, Alavattam Sreedhara, Jakob W. Buecheler, Sebastian Brosig, Danny K. Chou, Twinkle R. Christian, Tapan Kanti Das, Isabella de Jong, Jonas L. Fast, Bharat Jagannathan et al. · 2022 · The AAPS Journal
  10. Scalable manufacturing of gene-modified human mesenchymal stromal cells with microcarriers in spinner flasks
    Pedro Silva Couto, Dale J. Stibbs, Marco C. Rotondi, Yasuhiro Takeuchi, Qasim A. Rafiq · 2023 · Applied Microbiology and Biotechnology
  11. Development of KoRV-pseudotyped lentiviral vectors for efficient gene transfer into freshly isolated immune cells
    Alexander Renner, Anika Stahringer, Katharina Eva Ruppel, Stephan Fricke, Ulrike Koehl, Dominik Schmiedel · 2024 · Gene Therapy
  12. A novel scalable, robust downstream process for oncolytic rat parvovirus: isoelectric point-based elimination of empty particles
    Barbara Leuchs, Veronika Frehtman, Markus Riese, Marcus Christian Müller, Jean Rommelaere · 2017 · Applied Microbiology and Biotechnology
  13. Generation of Knockout Human Primary Keratinocytes by CRISPR/Cas9
    Serena Grossi, Gabriele Fenini, Paulina Hennig, Michela Di Filippo, Hans‐Dietmar Beer · 2019 · Methods in molecular biology
  14. Interference chromatography: a novel approach to optimizing chromatographic selectivity and separation performance for virus purification
    Lisa A. Santry, Renaud Jacquemart, Melissa Vandersluis, Mochao Zhao, Jake M. Domm, Thomas M. McAusland, Xiaojiao Shang, Pierre M. Major, James G. Stout, Sarah K. Wootton · 2020 · BMC Biotechnology
  15. Viral and non-viral vectors for gene therapy in the treatment of bone-related disorders: molecular insights and clinical perspectives
    Heng’an Ge, Zhenting Shi, Centao Liu, Jingwei Lu, Ying Yao, Biao Cheng · 2025 · Molecular Aspects of Medicine
  16. Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture
    Saqlain Suleman, Serena Fawaz, Terry Roberts, Stuart M. Ellison, Brian Bigger, Michael Themis · 2024 · Journal of Virological Methods
  17. Establishment and Characterization of a Stable Producer Cell Line Generation Platform for the Manufacturing of Clinical-Grade Lentiviral Vectors
    Ane Arrasate, Igone Bravo, Carlos Lopez-Robles, Ane Arbelaiz-Sarasola, Maddi Ugalde, Martha Lucia Meijueiro, Miren Zuazo, Ana Valero, Soledad Baños-Mateos, Juan Carlos Ramı́rez et al. · 2024 · Biomedicines
  18. Clinical grade lentiviral vector purification and quality control requirements
    Ruina Shi, Shenghua Jia, Huwei Liu, Honggang Nie · 2022 · Journal of Separation Science
  19. High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy
    Hazal Banu Olgun Celebioglu, Hale M. Tasyurek, Ahter Dilşad Şanlioğlu, Salih Şanlıoğlu · 2018 · Methods in molecular biology
  20. Lentivirus Manufacturing Process for Primary T‐Cell Biofactory Production
    Harikrishnan Radhakrishnan, Harold S. Javitz, Parijat Bhatnagar · 2020 · Advanced Biosystems
  21. Trojan Horse-Like Vehicles for CRISPR-Cas Delivery: Engineering Extracellular Vesicles and Virus-Like Particles for Precision Gene Editing in Cystic Fibrosis
    Laudonia Lidia Dipalo, Jacob Giehm Mikkelsen, Rik Gijsbers, Marianne Sylvia Carlon · 2025 · Human Gene Therapy
  22. Generation of stable suspension producer cell lines for serum‐free lentivirus production
    Maximilian Klimpel, Monica Cristina Terrão, Melina Bräuer, Herbert Dersch, Martina Biserni, Larissa Mélo do Nascimento, Sarah Schwingal, Jessica E. Vogel, Cathrin Ferlemann, Tobias Brandt et al. · 2024 · Biotechnology Journal
  23. Integrasone Derivatives Isolated from Lepteutypa sp. KT4162 and Their Anti-HIV-1 Integrase Activity
    Satomi Miura, Kotaro Ishida, Kazuaki Tanaka, Eiji Morita, Masaru Hashimoto · 2023 · Journal of Natural Products
  24. Forced expression of HOXA13 confers oncogenic hallmarks to esophageal keratinocytes
    Kateryna Nesteruk, Vincent T. Janmaat, Hui Liu, Timo L.M. ten Hagen, Maikel Petrus Peppelenbosch, Gwenny Manel Fuhler · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  25. Lentiviral mediated gene delivery as an effective therapeutic approach for Parkinson disease
    Violina Kakoty, K C Sarathlal, Sunil Kumar Dubey, Chih Hao Yang, Prashant Kesharwani, Rajeev Taliyan · 2021 · Neuroscience Letters
  26. A platform method for plasmid isoforms analysis by capillary gel electrophoresis
    Meng Wang, Jun‐Kai Liu, Tie Gao, Ling‐Li Xu, Xiaoxia Zhang, Jianhui Nie, Yan Li, Hong‐Xu Chen · 2022 · Electrophoresis
  27. Mitofusin2 regulates the proliferation and function of fibroblasts: The possible mechanisms underlying pelvic organ prolapse development
    Xiaoqing Wang, Xiaoxiao Wang, Yingfang Zhou, Chao Peng, Huayun Chen, Ye Feng Lu · 2019 · Molecular Medicine Reports
  28. Lentiviral vector packaging and producer cell lines yield titers equivalent to the industry-standard four-plasmid process
    Matthew Tridgett, Marie Mulet, S. Parokkaran Johny, Maria Ababi, M. Raghunath, Chloé Fustinoni, Boryana Galabova, Cristina Fernández-Díaz, Iveta Mikalajūnaitė, Hélio A. Tomás et al. · 2024 · Molecular Therapy — Methods & Clinical Development
  29. Culture media selection and feeding strategy for high titer production of a lentiviral vector by stable producer clones cultivated at high cell density
    Chun Fang Shen, Sonia Tremblay, Catherine Sabourin-Poirier, Elodie Burney, Sophie Broussau, Aziza P. Manceur, Anja Rodenbrock, Robert Voyer, Martin Loignon, Sven Ansorge et al. · 2022 · Bioprocess and Biosystems Engineering
  30. Exploring nutrient supplementation and bioprocess optimization to improve the production of lentiviral vectors in serum‐free medium suspension cultures
    Tiago André Gonçalves Vaz, Ana F. Rodrigues, Ana Sofia Coroadinha · 2023 · Biotechnology Journal
  31. Selecting a Cell Engineering Methodology During Cell Therapy Product Development
    Lauren M. Timmins, Alexandra Burr, Kristina Carroll, Robert Keefe, Matthew Teryek, L J Cantolupo, Johannes C.M. van der Loo, Thomas R.J. Heathman, Adam J. Gormley, David W. Smith et al. · 2021 · Cell Transplantation
  32. A review of the underlying genetics and emerging therapies for canine cardiomyopathies
    Leping Shen, Amara H. Estrada, Kathryn M. Meurs, M. Sleeper, Chris D. Vulpe, Christopher Joseph Martyniuk, Christina A. Pacak · 2021 · Journal of Veterinary Cardiology
  33. Development of novel lipoplex formulation methodologies to improve large-scale transient transfection for lentiviral vector manufacture
    Thomas Williams-Fegredo, Lee Davies, Carol Knevelman, Kyriacos A. Mitrophanous, James Miskin, Qasim A. Rafiq · 2024 · Molecular Therapy — Methods & Clinical Development
  34. Retroviral Vector Technology for Gene Therapy: History, Current Landscape, and Future Prospects
    Soumeya Ali Jaballah, Lizna Mohamed Ali, Mohammad Abdullah Jehad, Shaima Akhlaq, Tahir Aziz Rizvi, Farah Mustafa · 2025 · Journal of Molecular Biology
  35. Enhancing recombinant protein and viral vector production in mammalian cells by targeting the YTHDF readers of N6‐methyladenosine in mRNA
    Nga Thi Lao, Niall Barron · 2023 · Biotechnology Journal
  36. Liter-scale manufacturing of shelf-stable plasmid DNA/PEI transfection particles for viral vector production
    Yizong Hu, Brendan A. Eder, Jinghan Lin, Sixuan Li, Yining Zhu, Tza‐Huei Wang, Ting Guo, Hai‐Quan Mao · 2024 · Molecular Therapy — Methods & Clinical Development
  37. Protection of Lymphocytes Against HIV using Lentivirus Vector Carrying a Combination of TRIM5α-HRH Genes and microRNA Against CCR5
    Denis O. Omelchenko, Dina Viktorovna Glazkova, Elena Vladimirovna Bogoslovskaya, Ф. А. Урусов, Ю.А. Жогина, Г. М. Цыганова, German Alexandrovich Shipulin · 2018 · Molecular Biology
  38. Efficient clinical-grade γ-retroviral vector purification by high-speed centrifugation for CAR T cell manufacturing
    Leila Mekkaoui, Jose G. Tejerizo, Sara Abreu, Lydie Rubat, Aleksandra Nikoniuk, William Macmorland, Claire Horlock, Sofia Matsumoto, Sarah Williams, Koval Smith et al. · 2022 · Molecular Therapy — Methods & Clinical Development
  39. Cancer Gene Therapy: Development and Production of Lentiviral Vectors for Gene Therapy
    Ana Sofia Coroadinha · 2022 · Methods in molecular biology
  40. Developing a process of lentivirus purification from recombinant fluids using peptide affinity ligands
    Eduardo Barbieri, Gina N. Mollica, Sobhana Alekhya Sripada, Shrirarjun Shastry, Yuxuan Wu, Arianna Minzoni, William Kojo Smith, Elena Wüstenhagen, Annika Aldinger, Heiner Graalfs et al. · 2025 · Bioengineering & Translational Medicine
  41. CAMTA1–PPP3CA–NFATc4 multi-protein complex mediates the resistance of colorectal cancer to oxaliplatin
    Ruijun Pan, Zhou Zhang, Hongtao Jia, Junjun Ma, Chao Wu, Pei Xue, Wei Cai, Xiaoping Zhang, Jing Ping Sun · 2022 · Cell Death Discovery
  42. Optimizing and developing a scalable, chemically defined, animal component-free lentiviral vector production process in a fixed-bed bioreactor
    Carme Ripoll Fiol, Marie-Laure Collignon, John Welsh, Qasim A. Rafiq · 2023 · Molecular Therapy — Methods & Clinical Development
  43. Stable Expression by Lentiviral Transduction of Cells
    Natascha Gödecke, H. Häuser, Dagmar Wirth · 2018 · Methods in molecular biology
  44. Generation of High-Titer Pseudotyped Lentiviral Vectors
    Shuang Hu, Mingjie Li, Ramesh Akkina · 2019 · Methods in molecular biology
  45. Modulation of N-Methyl-N-nitrosourea Mutagenesis in Mouse Embryo Fibroblasts Derived from the gpt Delta Mouse by an Inhibitor of the O6-Methylguanine Methyltransferase, MGMT
    Pennapa Thongararm, Bogdan I. Fedeles, Sakunchai Khumsubdee, Amanda L. Armijo, Lina Kim, Apinya Thiantanawat, Jeerawan Promvijit, Panida Navasumrit, Mathuros Ruchirawat, Robert G. Croy et al. · 2019 · Chemical Research in Toxicology
  46. Production of High-Titer Lentiviral Particles for Stable Genetic Modification of Mammalian Cells
    Michael R. Larcombe, Jan Manent, Joseph Chen, Ketan Mishra, Xiaodong Liu, Christian Maximilian Nefzger · 2019 · Methods in molecular biology
  47. Development of a laboratory scalable process for enhancing lentivirus production by transient transfection of HEK293 adherent cultures
    Yoon Khei Ho, Heng‐Phon Too · 2020 · Gene Therapy
  48. Engineering a Synthesis-Friendly Constitutive Promoter for Mammalian Cell Expression
    Chee Ka Candice Lam, Kevin Truong · 2020 · ACS Synthetic Biology
  49. Quasi-perfusion studies for intensified lentiviral vector production using a continuous stable producer cell line
    Dale J. Stibbs, Pedro Silva Couto, Yasuhiro Takeuchi, Qasim A. Rafiq, Nigel B. Jackson, Andrea C. M. E. Rayat · 2024 · Molecular Therapy — Methods & Clinical Development
  50. Overexpression of USP35 enhances the protective effect of hUC-MSCs and their extracellular vesicles in oxygen-glucose deprivation/reperfusion-induced SH-SY5Y cells via stabilizing FUNDC1
    Shuo Wang, Xigong Li, Tianjiao Wang, Zeyu Sun, Erwei Feng, Yongming Jin · 2024 · Communications Biology
  51. Challenges in lentiviral vector production: retro-transduction of producer cell lines
    Maximilian Klimpel, Christin Obert, Monica Cristina Terrão, Parameswari Singh, Haiyan Wei, Chao‐Guang Chen, Andreas Gille, Silke Wissing, Holger Laux · 2025 · Frontiers in Bioengineering and Biotechnology
  52. Membrane adsorber design for lentiviral vector recovery
    George Pamenter, Danyal H Rahim, Ciaran M. Lamont, Maria Kapanidou, Kirstie Pemberton, Rui Sanches, Anurag Kulkarni, Oliver Charles Goodyear, Carol Knevelman, Kyriacos A. Mitrophanous et al. · 2025 · Molecular Therapy — Methods & Clinical Development
  53. Challenges and Opportunities in Lentivirus Viral Vector Manufacturing for In Vivo Applications
    Eduardo Barbieri, Caryn L. Heldt · 2026 · Biomedicines
  54. Transition from serum-supplemented monolayer to serum-free suspension lentiviral vector production for generation of chimeric antigen receptor T cells
    Mariane Cariati Tirapelle, Ana Luiza Oliveira Lomba, Renata Nacasaki Silvestre, Amanda Mizukami, Dimas Tadeu Covas, Virgínia Picanço‐Castro, Kamilla Swiech · 2022 · Cytotherapy
  55. Efficient and simple genetic engineering of enteroids using mouse isolated crypts for investigating intestinal functions
    Shuya Ohira, Yuki Yokoi, Tokiyoshi Ayabe, Kiminori Nakamura · 2022 · Biochemical and Biophysical Research Communications
  56. Pseudotyped Viruses for Retroviruses
    Magan Solomon, Chen Liang · 2023 · Advances in experimental medicine and biology
  57. Overview of Current Downstream Processing for Modern Viral Vectors
    Paul Cashen, Katy A. McLaughlin · 2023 · Springer eBooks
  58. Uncertainty quantification for gene delivery methods: A roadmap for pDNA manufacturing from phase I clinical trials to commercialization
    Niki Triantafyllou, Miriam Sarkis, Aikaterina Krassakopoulou, Nilay Shah, Maria M. Papathanasiou, Cleo Kontoravdi · 2023 · Biotechnology Journal
  59. Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal function
    Cristóbal Cerda‐Troncoso, Felipe Grünenwald, Eloísa Arias‐Muñoz, Viviana A. Cavieres, Albano Cáceres‐Verschae, Sergio Hernández, Belén Gaete‐Ramírez, Francisca Álvarez‐Astudillo, Rodrigo A. Acuña, Matías Ostrowski et al. · 2024 · Journal of Extracellular Biology
  60. Scale-up of lentiviral vectors for gene therapy: advances and challenges
    Alexandra McCarron, Martin Donnelley, David Parsons · 2017 · Cell and Gene Therapy Insights
  61. In vivo CAR T cell generation using retargeted and functionalized lentiviral vectors with reduced immunogenicity
    Kyrellos E. Ibrahim, Kepler S. Mears, Peter M. Allen, Jordan M. Chinai, Omar I. Avila, Audrey J. Muscato, Sarah Kate Lane-Reticker, Alexánder Rojas, Nelson H. Knudsen, Chun‐Cheih Chao et al. · 2026 · Nature Communications
  62. An efficient low cost means of biophysical gene transfection in primary cells
    Shudi Huang, Tyler R. Henderson, Chesarahmia Dojo Soeandy, Anastasiya Lezhanska, Jeffrey Theodore Henderson · 2024 · Scientific Reports
  63. Non‐industrial production of therapeutic lentiviral vectors: How to provide vectors to academic CAR‐T
    Viktoriya V. Keyer, Laura Syzdykova, Bakytkali Ingirbay, Elena S. Sedova, Gulzat Zauatbayeva, Tolganay Kulatay, Alexandr Shevtsov, Alexandr V. Shustov · 2024 · Biotechnology and Bioengineering
  64. Investigating Ultrafiltration Membranes and Operation Modes for Improved Lentiviral Vector Processing
    Jennifer J. Labisch, Maria Evangelopoulou, T. Schleuß, Andreas Pickl · 2025 · Engineering in Life Sciences
  65. Viral Vectors for Gene Therapy
    Clévio Nóbrega, Liliana S. Mendonça, Carlos A. Matos · 2020 · Springer eBooks
  66. Gene-modified, cell-based therapies—an overview
    Allison B. Powell, Kiara Williams, Carolina Colli Cruz · 2016 · Cytotherapy
  67. Lentiviral Vectors Delivered with Biomaterials as Therapeutics for Spinal Cord Injury
    Ciara Shortiss, Linda Howard, Siobhán S. McMahon · 2021 · Cells
  68. Lentiviral Vector Production in Suspension Culture Using Serum-Free Medium for the Transduction of CAR-T Cells
    Aline Do Minh, Michelle Yen Tran, Amine Kamen · 2019 · Methods in molecular biology
  69. Depth filtration for clarification of intensified lentiviral vector suspension cell culture
    Mukesh Mayani, Srinivas Nellimarla, Ratish Mangalathillam, Hema Rao, Susannah L. Patarroyo-White, Junfen Ma, Bruno Figueroa · 2023 · Biotechnology Progress
  70. Gene Delivery via Octadecylamine-Based Nanoparticles for iPSC Generation from CCD1072-SK Fibroblast Cells
    Hanife Sevgi Varlı, Meryem Akkurt Yıldırım, Kadriye Kızılbey, Nelisa Türkoğlu Laçin · 2024 · Current Issues in Molecular Biology
  71. Enhancing titers of therapeutic lentiviral vectors using PKC agonists
    Charles Moore-Kelly, Rajesh Reddem, B. M. Alberts, Jordan Wright, T. Evans, Anurag Kulkarni, Nicholas G. Clarkson, D. Farley, K. Mitrophanous, Rui André Saraiva Raposo · 2025 · Molecular Therapy: Methods & Clinical Development
  72. Serum-free lentiviral vector production is compatible with medium-resident nuclease activity arising from adherent HEK293T host cells engineered with a nuclease-encoding transgene
    Sadfer Ali, Milena Rivera, John Maxim Ward, Eli Keshavarz‐Moore, Chris Mason, Darren Nesbeth · 2023 · Heliyon
  73. Phase I/II Manufacture of Lentiviral Vectors Under GMP in an Academic Setting
    Anindya Dasgupta, Stuart L. Tinch, Kathleen Szczur, Rebecca Ernst, Nathaniel Shryock, Courtney Kaylor, Kendall Lewis, Eric Day, Timmy Truong, William P. Swaney · 2019 · Methods in molecular biology
  74. Identification of ADAR1 p150 and p110 Associated Edit Sites
    Tony Sun, Brad R. Rosenberg, Hachung Chung, Charles M. Rice · 2023 · Methods in molecular biology
  75. Production of Therapeutic Enzymes by Lentivirus Transgenesis
    María Celeste Rodríguez, Natalia Ceaglio, Sebastián Antuña, María Belén Tardivo, Marina Etcheverrigaray, Claudio C. Prieto · 2019 · Advances in experimental medicine and biology
  76. Real-time transfer of lentiviral particles by producer cells using an engineered coculture system
    Lauren M. Timmins, Riya S. Patel, Matthew Teryek, Biju Parekkadan · 2019 · Cytotechnology
  77. Development of Lentiviral Packaging Cells and Scale Up of Production to Meet the Growing Demand in Cell and Gene Therapy
    Yasemin van Heuvel, Jörn Stitz · 2025 · Current Gene Therapy
  78. A novel pseudotype derived of the canine distemper virus for adapter-mediated lentiviral transduction in vivo
    Nora Winter, Carolin Kolbe, Shima Ferdos, Larissa Steiner, Nils Bartelsen, Dominik Lock, Fabian Engert, Boris Engels, Mario Assenmacher, Michael Schindler et al. · 2025 · Molecular Therapy — Methods & Clinical Development
  79. Enhancing lentiviral production for WAS gene therapy: a comparative analysis of stable producer cell lines evaluating flatware system and adherent bioreactors in perfusion mode
    Parameswari Singh, Nikki Indresh Lal, Monica Cristina Terrão, Sarah Schwingal, Martina Biserni, Florian Aeschimann, Andrea Strauch, Herbert Dersch, Angel Jaramillo, Andreas Gille et al. · 2025 · Frontiers in Bioengineering and Biotechnology
  80. Nano-Bio Interfaces: Pioneering Targeted Approaches for Disease Treatment and Prevention
    Dilpreet Singh · 2024 · Journal of Macromolecular Science Part B
  81. High yield process for the production of active human α‐galactosidase a in CHO‐K1 cells through lentivirus transgenesis
    María Celeste Rodríguez, Natalia Ceaglio, Sebastián Antuña, María Belén Tardivo, Marina Etcheverrigaray, Claudio C. Prieto · 2017 · Biotechnology Progress
  82. A standard procedure for lentiviral‐mediated labeling of murine mesenchymal stromal cells in vitro
    Ana‐Mihaela Lupan, Mihai Bogdan Preda, Alexandrina Burlacu · 2019 · Biotechnology and Applied Biochemistry
  83. Advancing a rapid, high throughput screening platform for optimization of lentivirus production
    Sneha Gopal, Adam Osborne, Lindsay A. Hock, Jill M. Zemianek, Kun Fang, Gretchen V. Gee, Ronit Ghosh, David McNally, Steven M. Cramer, Jonathan S. Dordick · 2021 · Biotechnology Journal
  84. Effective Transduction of Brain Neurons with Lentiviral Vectors Purified via Ion-Exchange Chromatography
    Elizaveta V. Shaburova, Dmitriy A. Lanshakov · 2021 · Applied Biochemistry and Microbiology
  85. Hitching a Ride: Enhancing Nucleic Acid Delivery into Target Cells Through Nanoparticles
    Alekhya Penumarthi, Preetam Basak, Peter M. Smooker, Ravi Shukla · 2020 · Environmental chemistry for a sustainable world
  86. Packaging of Single-Stranded RNA in Viruses and Virus-Like Particles
    Rees F. Garmann, William M. Gelbart · 2026 · Annual Review of Biochemistry
  87. DC-targeting lentivectors for cancer immunotherapy
    Ester Gea‐Mallorquí, Sarah Rowland‐Jones · 2023 · Immunotherapy Advances
  88. Engineered CAR-T cells: An immunotherapeutic approach for cancer treatment and beyond
    Purva Khodke, Bajarang Vasant Kumbhar · 2024 · Advances in protein chemistry and structural biology
  89. Bioprocess Development and Bioreactor Scale-Up for the Production of Recombinant Lentiviral Viral Vectors in HEK293 Suspension Cell Culture
    Julien Robitaille, Aziza P. Manceur, Anja Rodenbrock, Martin Loignon · 2024 · Biochemistry
  90. The ecto-enzyme CD38 modulates CD4T cell immunometabolic responses and participates in HIV pathogenesis
    Fernando Díaz-Basilio, Moises Vergara‐Mendoza, Jessica Romero-Rodríguez, Sharik Hernández-Rizo, Alejandro Escobedo‐Calvario, L. Leon-Fuentes, Santiago Pérez-Patrigeón, Akio Murakami-Ogasawara, María Gómez-Palacio, Gustavo Reyes‐Terán et al. · 2024 · Journal of Leukocyte Biology
  91. Comprehensive untargeted lipidomic profiling of third generation lentiviral vectors and packaging cells
    Joshua A Roberts, Elena Godbout, Jocelyn A. Menard, Christopher N. C. Boddy, Jean‐Simon Diallo, Jeffrey C. Smith · 2024 · Molecular Omics
  92. Overcoming lentiviral delivery limitations in hard-to-transduce suspension cells for genome-wide CRISPR screening
    Antonino Napoleone, Ivy Rose Sebastian, Federico De Marco, Alexander Molin, Mohamed Hussein, Lovro Kramer, Thomas Jostock, Thomas Kelly, Nicole Borth · 2026 · Molecular Therapy Advances
  93. Foamy Virus Integrase in Development of Viral Vector for Gene Therapy
    Jin‐Sun Kim, Ga‐Eun Lee, Cha‐Gyun Shin · 2020 · Journal of Microbiology and Biotechnology
  94. Process for production of chimeric antigen receptor-transducing lentivirus particles using infection with replicon particles containing self-replicating RNAs
    Laura Syzdykova, Gulzat Zauatbayeva, Viktoriya V. Keyer, Yerlan Ramanculov, Roman Arsienko, Alexandr V. Shustov · 2023 · Biochemical Engineering Journal
  95. Anti-tumor Efficacy of CD19 CAR-T in a Raji B Cell Xenografted Mouse Model
    Qian Xiao, Xiaolei Su · 2023 · BIO-PROTOCOL
  96. PE-STOP: A versatile tool for installing nonsense substitutions amenable for precise reversion
    Ziguo Song, Guiquan Zhang, Shuhong Huang, Yao Liu, Guanglei Li, Xianhui Zhou, Jiayuan Sun, Pengfei Gao, Yulin Chen, Xingxu Huang et al. · 2023 · Journal of Biological Chemistry
  97. Present Situation of Viral Vector Manufacturing and Ways to Overcome Potential Barriers in View of the Routine Large Scale Production and Use of Viral Vectors
    O-W Merten · 2017 · Current Trends in Biomedical Engineering & Biosciences
  98. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. V: Manufacture and quality control
    Gil Cunha De Santis, Dante Mário Langhi, Andreza Feitoza, Alfredo Mendrone, José Mauro Kutner, Dimas Tadeu Covas, Samuel Campanelli Freitas Couto, Renato Cunha, Maristela Delgado Orellana, Silvia Renata Cornélio Parolin Rizzo · 2021 · Hematology Transfusion and Cell Therapy
  99. Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for Refractory B-Cell Lymphoma In Vitro and In Vivo
    Yuzhen Yin, Pengchao Zhang, Ling He, Xianling Guo, Hui Wang, Jun Li, Qing Xu · 2022 · Evidence-based Complementary and Alternative Medicine · Retracted
  100. Improvement of De Novo Cholesterol Biosynthesis Efficiently Promotes the Production of Human Immunodeficiency Virus Type 1-Derived Lentiviral Vectors
    Nathalie Holic, Sophie Frin, Ababacar K. Seye, Anne H. M. Galy, David Fenard · 2017 · Human Gene Therapy Methods